207 related articles for article (PubMed ID: 17659576)
1. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma.
Yuan JM; Lu SC; Van Den Berg D; Govindarajan S; Zhang ZQ; Mato JM; Yu MC
Hepatology; 2007 Sep; 46(3):749-58. PubMed ID: 17659576
[TBL] [Abstract][Full Text] [Related]
2. Association of MTHFR and TYMS gene polymorphisms with the susceptibility to HCC in Egyptian HCV cirrhotic patients.
Abdel Allah HMM; Zahran WE; El-Masry SA; El-Bendary M; Soliman AF
Clin Exp Med; 2022 May; 22(2):257-267. PubMed ID: 34297238
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer.
Lin S; Yue J; Guan X; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Cancer Commun (Lond); 2019 Oct; 39(1):57. PubMed ID: 31601265
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
6. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease.
Vijaya Lakshmi SV; Naushad SM; Rupasree Y; Seshagiri Rao D; Kutala VK
J Atheroscler Thromb; 2011; 18(1):56-64. PubMed ID: 20962453
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
[TBL] [Abstract][Full Text] [Related]
9. The influence of methylenetetrahydrofolate reductase and thymidylate synthetase gene polymorphisms on lung adenocarcinoma occurrence.
Cavic M; Krivokuca A; Spasic J; Brotto K; Malisic E; Radosavljevic D; Radulovic S; Jankovic R
J BUON; 2014; 19(4):1024-8. PubMed ID: 25536611
[TBL] [Abstract][Full Text] [Related]
10. Folate metabolism-related gene polymorphisms and susceptibility to primary liver cancer in North China.
Cui LH; Song Y; Si H; Shen F; Shin MH; Kim HN; Choi JS
Med Oncol; 2012 Sep; 29(3):1837-42. PubMed ID: 21956592
[TBL] [Abstract][Full Text] [Related]
11. Influence of polymorphisms in MTHFR 677 C→T, TYMS 3R→2R and MTR 2756 A→G on NSCLC risk and response to platinum-based chemotherapy in advanced NSCLC.
Cui LH; Yu Z; Zhang TT; Shin MH; Kim HN; Choi JS
Pharmacogenomics; 2011 Jun; 12(6):797-808. PubMed ID: 21605004
[TBL] [Abstract][Full Text] [Related]
12. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study.
Inoue M; Robien K; Wang R; Van Den Berg DJ; Koh WP; Yu MC
Carcinogenesis; 2008 Oct; 29(10):1967-72. PubMed ID: 18669903
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple myeloma risk.
Lima CS; Ortega MM; Ozelo MC; Araujo RC; De Souza CA; Lorand-Metze I; Annichino-Bizzacchi JM; Costa FF
Leuk Res; 2008 Mar; 32(3):401-5. PubMed ID: 17655928
[TBL] [Abstract][Full Text] [Related]
14. Tyms double (2R) and triple repeat (3R) confers risk for human oral squamous cell carcinoma.
Bezerra AM; Sant'Ana TA; Gomes AV; de Lacerda Vidal AK; Muniz MT
Mol Biol Rep; 2014 Dec; 41(12):7737-42. PubMed ID: 25341694
[TBL] [Abstract][Full Text] [Related]
15. MTHFR Knockdown Assists Cell Defense against Folate Depletion Induced Chromosome Segregation and Uracil Misincorporation in DNA.
Wu MT; Ye WT; Wang YC; Chen PM; Liu JY; Tai CK; Tang FY; Li JR; Liu CC; Chiang EI
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502300
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences.
Inoue S; Hashiguchi M; Chiyoda T; Sunami Y; Tanaka T; Mochizuki M
Pharmacogenomics; 2007 Jan; 8(1):41-7. PubMed ID: 17187508
[TBL] [Abstract][Full Text] [Related]
17. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphism analysis of MTHFR，BMPR1B and TYMS in microtia].
Liu N; Liu YF; Sui J; Zhang YQ; Ma SM; Wu WJ; Liang G; Tan Q
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(6):409-414. PubMed ID: 29871275
[No Abstract] [Full Text] [Related]
19. Association between methylenetetrahydrofolate reductase tagging polymorphisms and susceptibility of hepatocellular carcinoma: a case-control study.
Zhang S; Lin J; Jiang J; Chen Y; Tang W; Liu L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694048
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer.
Wang L; Miao X; Tan W; Lu X; Zhao P; Zhao X; Shan Y; Li H; Lin D
Clin Gastroenterol Hepatol; 2005 Aug; 3(8):743-51. PubMed ID: 16234002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
